The Priority Review

Tag

HFA-152a

1 story

  1. Clinical trials

    GlaxoSmithKline posts results of Phase 3 salbutamol safety study

    Results for this study were first posted on ClinicalTrials.gov on October 6, 2026, for a Phase 3 trial that enrolled 471 participants. The study began May 31, 2024 and completed primary data collection on September 2, 2025.